H

Hyphens Pharma International Ltd
SGX:1J5

Watchlist Manager
Hyphens Pharma International Ltd
SGX:1J5
Watchlist
Price: 0.295 SGD 1.72%
Updated: May 23, 2024

Intrinsic Value

Hyphens Pharma International Ltd. is an investment holding company, which engages in the provision of specialty pharmaceutical and consumer healthcare products. [ Read More ]

The intrinsic value of one 1J5 stock under the Base Case scenario is hidden SGD. Compared to the current market price of 0.295 SGD, Hyphens Pharma International Ltd is hidden .

Key Points:
1J5 Intrinsic Value
HIDDEN
Unlock
Worst Case
Base Case
Best Case

Valuation Backtest
Hyphens Pharma International Ltd

Backtest Intrinsic Value
Dive into the past to invest in the future

Run backtest to discover the historical profit from buying and selling 1J5 stocks based on their intrinsic value.

Analyze the historical link between intrinsic value and market price to make more informed investment decisions.

Run Backtest
Settings
Valuation Methods
Buy/Sell Thresholds
Buy When:
%
Sell When:
%
B
S
Run Backtest
How does it work?

Fundamental Analysis

Beta
Ask me anything about
Hyphens Pharma International Ltd

Provide an overview of the primary business activities
of Hyphens Pharma International Ltd.

What unique competitive advantages
does Hyphens Pharma International Ltd hold over its rivals?

What risks and challenges
does Hyphens Pharma International Ltd face in the near future?

Is it considered overvalued or undervalued
based on the latest financial data?

Show all valuation multiples
for Hyphens Pharma International Ltd.

Provide P/S
for Hyphens Pharma International Ltd.

Provide P/E
for Hyphens Pharma International Ltd.

Provide P/OCF
for Hyphens Pharma International Ltd.

Provide P/FCFE
for Hyphens Pharma International Ltd.

Provide P/B
for Hyphens Pharma International Ltd.

Provide EV/S
for Hyphens Pharma International Ltd.

Provide EV/GP
for Hyphens Pharma International Ltd.

Provide EV/EBITDA
for Hyphens Pharma International Ltd.

Provide EV/EBIT
for Hyphens Pharma International Ltd.

Provide EV/OCF
for Hyphens Pharma International Ltd.

Provide EV/FCFF
for Hyphens Pharma International Ltd.

Provide EV/IC
for Hyphens Pharma International Ltd.

Show me price targets
for Hyphens Pharma International Ltd made by professional analysts.

What are the Revenue projections
for Hyphens Pharma International Ltd?

How accurate were the past Revenue estimates
for Hyphens Pharma International Ltd?

What are the Net Income projections
for Hyphens Pharma International Ltd?

How accurate were the past Net Income estimates
for Hyphens Pharma International Ltd?

What are the EPS projections
for Hyphens Pharma International Ltd?

How accurate were the past EPS estimates
for Hyphens Pharma International Ltd?

What are the EBIT projections
for Hyphens Pharma International Ltd?

How accurate were the past EBIT estimates
for Hyphens Pharma International Ltd?

Compare the revenue forecasts
for Hyphens Pharma International Ltd with those of its competitors based on recent analyst estimates.

Compare the intrinsic valuations
of Hyphens Pharma International Ltd and its key competitors using the latest financial data.

Compare historical revenue growth rates
of Hyphens Pharma International Ltd against its competitors.

Analyze the profit margins
(gross, operating, and net) of Hyphens Pharma International Ltd compared to its peers.

Compare the P/E ratios
of Hyphens Pharma International Ltd against its peers.

Discuss the investment returns and shareholder value creation
comparing Hyphens Pharma International Ltd with its peers.

Analyze the financial leverage
of Hyphens Pharma International Ltd compared to its main competitors.

Show all profitability ratios
for Hyphens Pharma International Ltd.

Provide ROE
for Hyphens Pharma International Ltd.

Provide ROA
for Hyphens Pharma International Ltd.

Provide ROIC
for Hyphens Pharma International Ltd.

Provide ROCE
for Hyphens Pharma International Ltd.

Provide Gross Margin
for Hyphens Pharma International Ltd.

Provide Operating Margin
for Hyphens Pharma International Ltd.

Provide Net Margin
for Hyphens Pharma International Ltd.

Provide FCF Margin
for Hyphens Pharma International Ltd.

Show all solvency ratios
for Hyphens Pharma International Ltd.

Provide D/E Ratio
for Hyphens Pharma International Ltd.

Provide D/A Ratio
for Hyphens Pharma International Ltd.

Provide Interest Coverage Ratio
for Hyphens Pharma International Ltd.

Provide Altman Z-Score Ratio
for Hyphens Pharma International Ltd.

Provide Quick Ratio
for Hyphens Pharma International Ltd.

Provide Current Ratio
for Hyphens Pharma International Ltd.

Provide Cash Ratio
for Hyphens Pharma International Ltd.

What is the historical Revenue growth
over the last 5 years for Hyphens Pharma International Ltd?

What is the historical Net Income growth
over the last 5 years for Hyphens Pharma International Ltd?

What is the current Free Cash Flow
of Hyphens Pharma International Ltd?

Discuss the annual earnings per share (EPS)
trend over the past five years for Hyphens Pharma International Ltd.

Financials
Annual
Quarterly
TTM
Annual
Quarterly
TTM

Balance Sheet Decomposition
Hyphens Pharma International Ltd

Current Assets 92.2m
Cash & Short-Term Investments 24.2m
Receivables 40.4m
Other Current Assets 27.6m
Non-Current Assets 28.6m
PP&E 4.9m
Intangibles 23.6m
Other Non-Current Assets 172k
Current Liabilities 49.2m
Accounts Payable 44.3m
Other Current Liabilities 5m
Non-Current Liabilities 8.5m
Long-Term Debt 4.4m
Other Non-Current Liabilities 4.1m
Efficiency

Earnings Waterfall
Hyphens Pharma International Ltd

Revenue
170.6m SGD
Cost of Revenue
-108.7m SGD
Gross Profit
61.9m SGD
Operating Expenses
-49.6m SGD
Operating Income
12.3m SGD
Other Expenses
-3.7m SGD
Net Income
8.6m SGD

Free Cash Flow Analysis
Hyphens Pharma International Ltd

Last Value
3-Years Average
FCF Margin
Conversion Rate
History
Components
Chart
Table
Fundamental Scores

1J5 Profitability Score
Profitability Due Diligence

Hyphens Pharma International Ltd's profitability score is hidden . The higher the profitability score, the more profitable the company is.

Positive 3-Year Average ROIC
Positive Gross Profit
Positive 3-Years Revenue Growth
Positive Free Cash Flow
hidden
Profitability
Score

Hyphens Pharma International Ltd's profitability score is hidden . The higher the profitability score, the more profitable the company is.

1J5 Solvency Score
Solvency Due Diligence

Hyphens Pharma International Ltd's solvency score is hidden . The higher the solvency score, the more solvent the company is.

hidden
Solvency
Score

Hyphens Pharma International Ltd's solvency score is hidden . The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

1J5 Price Targets Summary
Hyphens Pharma International Ltd

Wall Street analysts forecast 1J5 stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for 1J5 is 0.357 SGD with a low forecast of 0.354 SGD and a high forecast of 0.368 SGD.

Lowest
Price Target
0.354 SGD
20% Upside
Average
Price Target
0.357 SGD
21% Upside
Highest
Price Target
0.368 SGD
25% Upside
View Analyst Estimates
View Analyst Estimates

Competitive Landscape

Competitors Analysis
Hyphens Pharma International Ltd

Shareholder Return

1J5 Price
Hyphens Pharma International Ltd

1M 1M
+7%
6M 6M
+5%
1Y 1Y
+0%
3Y 3Y
+4%
5Y 5Y
+66%
10Y 10Y
+24%
Annual Price Range
0.295
52w Low
0.265
52w High
0.31
Price Metrics
Average Annual Return 17.69%
Standard Deviation of Annual Returns 25.83%
Max Drawdown -54%
Shares Statistics
Market Capitalization 91.2m SGD
Shares Outstanding 300 430 400
Percentage of Shares Shorted
N/A

1J5 Return Decomposition
Main factors of price return

What is price return decomposition?

Company Profile

Hyphens Pharma International Ltd

Country

Singapore

Industry

Pharmaceuticals

Market Cap

91.2m SGD

Dividend Yield

2.92%

Description

Hyphens Pharma International Ltd. is an investment holding company, which engages in the provision of specialty pharmaceutical and consumer healthcare products. The firm's principal activities are those of an investment holding company and provision of management services. The firm's segments include specialty pharma principals, proprietary brands, and medical hypermart and digital. The specialty pharma principals segment is engaged in the business of marketing and selling a range of specialty pharmaceutical products with exclusivity in the relevant ASEAN countries. The proprietary brands segment is engaged in the business of developing, marketing and selling its own proprietary range of dermatological products and health supplement products. The medical hypermart and digital segment is a wholesaler of pharmaceuticals and medical supplies in Singapore, which the Company and its subsidiaries position itself as a medical hypermart for healthcare professionals, healthcare institutions and retail pharmacies.

Contact

16 Tai Seng Street, Level 4
+6562965751
https://www.hyphensgroup.com/

IPO

2018-05-18

Employees

-

Officers

Executive Chairman & CEO
Mr. See Wah Lim
Chief Financial Officer
Mr. Yufan Zhang
Chief Operating Officer
Mr. Yann Alain Marche
Chief People Officer
Jessica Tan
Head of Regulatory Affairs
Ms. Stella Ang
Country Head of Indonesia
Mr. Jamal Iflizar
Show More
Country Head of Malaysia
Mr. Ang Francis
Country Head of Philippines
Josiephine Sac Mantoya
Country Head of Vietnam
Laurence Fremy
Company Secretary
Ms. Sher Mei Lim C.A.
Show Less

See Also

Discover More
What is the Intrinsic Value of one 1J5 stock?

The intrinsic value of one 1J5 stock under the Base Case scenario is hidden SGD.

Is 1J5 stock undervalued or overvalued?

Compared to the current market price of 0.295 SGD, Hyphens Pharma International Ltd is hidden .